Digestive Diseases and Sciences

, Volume 50, Issue 12, pp 2330–2334 | Cite as

Pancreatic Autoantibodies in Greek Patients with Inflammatory Bowel Disease

  • Ioannis E. Koutroubakis
  • Dimitrios Drygiannakis
  • Konstantinos Karmiris
  • Ioannis Drygiannakis
  • Sokratis Makreas
  • Elias A. Kouroumalis


Pancreatic autoantibodies (PAbs) have been suggested as a specific but not sensitive marker for Crohn's disease (CD). The aim of this study was to assess the value of detecting PAbs in Greek patients with ulcerative colitis (UC) and CD. Sera were collected from 150 patients with IBD (73 with UC and 77 with CD), 31 cases with non-IBD intestinal inflammation, 16 cases with other autoimmune diseases, and 104 healthy controls. Determination of PAbs was performed by a standard indirect immunofluorescence technique. PAbs were detected in 18 of 73 (24.7%) samples from UC patients and in 32 of 77 (41.6%) samples from CD patients. The prevalence of positive PAbs was significantly higher in CD than in UC (P= 0.04). None of the 104 samples from healthy controls and the 31 cases with non-IBD intestinal inflammation had detectable PAbs. One patient with Sjogren's syndrome was PAbs positive. No association of PAbs with IBD activity, IBD localization, or medical treatment was found. Patients with stenotic CD had a significantly higher prevalence of PAbs positivity (60%) compared with patients with inflammatory (28.6%) and fistulizing (41.2%) disease (P= 0.02). The prevalence of PAbs in Greek CD patients was found to be similar to that in previous reports. In contrast to these studies we found also increased prevalence of PAbs in UC patients. These findings suggest that PAbs should be considered as a specific marker for IBD rather than for CD.


antibodies Crohn's disease pancreatic autoantibodies serology ulcerative colitis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vernier G, Sendid B, Poulain D, Colombel JF: Relevance of serologic studies in inflammatory bowel disease. Curr Gastroenterol Rep 6:482–487, 2004PubMedGoogle Scholar
  2. 2.
    Sandborn WJ: Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord 4:167–174, 2004PubMedGoogle Scholar
  3. 3.
    Koutroubakis IE, Petinaki E, Mouzas IA, Anagnostopoulou E, Vlachonikolis IG, Castanas E, Kouroumalis EA: Anti Saccharomyces cerevesiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol 96:449–454, 2001PubMedGoogle Scholar
  4. 4.
    Stocker W, Otte M, Ulrich S, Normann D, Stocker K, Jantschek G: Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis. Dtsch Med Wochenschr 109:1963–1969, 1984PubMedGoogle Scholar
  5. 5.
    Stocker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stocker K, Jantschek G, Scriba PC: Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl 139:41–52, 1987PubMedGoogle Scholar
  6. 6.
    Seibold F, Weber P, Jenss H, Wiedmann KH: Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut 32:1192–1197, 1991PubMedGoogle Scholar
  7. 7.
    Seibold F, Mork H, Tanza S, Muller A, Holzhuter C, Weber P, Scheurlen M: Pancreatic autoantibodies in Crohn's disease: a family study. Gut 40:481–484, 1997PubMedGoogle Scholar
  8. 8.
    Folwaczny C, Noehl N, Endres SP, Loeschke K, Fricke H: Antineutrophil and pancreatic autoantibodies in first–degree relatives of patients with inflammatory bowel disease. Scand J Gastroenterol 33:523–528, 1998PubMedGoogle Scholar
  9. 9.
    Klebl FH, Bataille F, Huy C, Hofstädter F, Schölmerich J, Rogler G: Association of antibodies to exocrine pancreas with subtypes of Crohn's disease. Eur J Gastroenterol Hepatol 17:73–77, 2005CrossRefPubMedGoogle Scholar
  10. 10.
    Joossens S, Vermeire S, Van Steen K, Godefridis G, Claessens G, Pierik M, Vlietinck R, Aerts R, Rutgeerts P, Bossuyt X: Pancreatic autoantibodies in inflammatory bowel disease. Inflamm Bowel Dis 10:771–777, 2004PubMedGoogle Scholar
  11. 11.
    Fricke H, Birkhofer A, Folwaczny C, Meister W, Scriba PC: Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease. Eur J Clin Invest 29:41–45, 1999CrossRefPubMedGoogle Scholar
  12. 12.
    Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 24:2–6, 1989Google Scholar
  13. 13.
    Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70:439–444, 1976PubMedGoogle Scholar
  14. 14.
    Walmsley RS, Ayres RC, Pounder RE, Allan RN: A simple clinical colitis activity index. Gut 43:29–32, 1998PubMedCrossRefGoogle Scholar
  15. 15.
    Muller-Ladner U, Scholmerich J: Pancreatic autoantibodies in Crohn's disease. Eur J Clin Invest 29:46–47, 1999CrossRefPubMedGoogle Scholar
  16. 16.
    Torok HP, Folwaczny C: Pancreatic autoantibodies in Crohn's disease: A feasible diagnostic tool? Eur J Gastroenterol Hepatol 17:37–39, 2005PubMedGoogle Scholar
  17. 17.
    Nishimori I, Yamamoto Y, Okazaki K, Morita M, Onodera M, Kino J, Tamura S, Yamamoto Y: Identification of autoantibodies to a pancreatic antigen in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Pancreas 9:374–381, 1994PubMedGoogle Scholar
  18. 18.
    Nakamura RM, Matsutani M, Barry M: Advances in clinical laboratory tests for inflammatory bowel disease. Clin Chim Acta 335:9–20, 2003CrossRefPubMedGoogle Scholar
  19. 19.
    Conrad K, Schmechta H, Klafki A, Lobeck G, Uhlig HH, Gerdi S, Henker J: Serological differentiation of inflammatory bowel diseases. Eur J Gastroenterol Hepatol 14:129–135, 2002CrossRefPubMedGoogle Scholar
  20. 20.
    Seibold F, Scheurlen M, Muller A, Jenss H, Weber P: Impaired pancreatic function in patients with Crohn's disease with and without pancreatic autoantibodies. J Clin Gastroenterol 22:202–206, 1996CrossRefPubMedGoogle Scholar
  21. 21.
    Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P: Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 7:8–15, 2001PubMedGoogle Scholar
  22. 22.
    Mow WS, Vasiliauskas EA, Lin YC, et al.: Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126:414–424, 2004CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Ioannis E. Koutroubakis
    • 1
  • Dimitrios Drygiannakis
    • 2
  • Konstantinos Karmiris
    • 1
  • Ioannis Drygiannakis
    • 2
  • Sokratis Makreas
    • 1
  • Elias A. Kouroumalis
    • 1
  1. 1.The Department of GastroenterologyUniversity HospitalHeraklionGreece
  2. 2.Laboratory of Biochemistry General Hospital of RethymnonCreteGreece

Personalised recommendations